Addmedica   Report issue

For profit Phase 2 Phase 4
Founded: Paris France (2005)
Status: No NME R&D (2005)

Organization Overview

First Clinical Trial
2009
NCT02516579
First Marketed Drug
2017
hydroxyurea (hydrea)
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

ADDMEDICA SAS | ADDMEDICA SASA